Isolation of CD34(+) cells with the Amgen cell selection system provides T, NK and tumor cell depletion of peripheral blood stem cells from breast cancer patients.

被引：0
|
作者：
Symann, M
Guillaume, T
Salmon, M
Briddell, R
Zilm, K
Canon, JL
Andre, M
Jurdan, M
Johnsen, H
Richel, D
Myltenyi, S
Ewen, C
McNiece, I
机构：
[1] HOP ST LUC,BRUSSELS,BELGIUM
[2] HERLEV HOSP,COPENHAGEN,DENMARK
[3] MST,ENSCHEDE,NETHERLANDS
[4] AMGEN INC,THOUSAND OAKS,CA
[5] AMCELL,SUNNYVALE,CA
来源：
EXPERIMENTAL HEMATOLOGY | 1997年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [11] Persistence of natural killer (NK) progenitor cells in cord blood following depletion of CD34 stem cells.
    Nguyen, OH
    Roberts, RL
    Long, Z
    Choi, SS
    Chhabra, VS
    Louie, C
    Ank, BJ
    Stiehm, ER
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 90A - 90A
  • [12] Persistance of natural killer (NK) progenitor cells in cord blood following depletion of CD34 stem cells.
    Nguyen, OH
    Roberts, RL
    Long, Z
    Choi, SS
    Chhabra, VS
    Louie, C
    Ank, BJ
    Stiehm, ER
    FASEB JOURNAL, 1998, 12 (05): : A906 - A906
  • [13] Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells
    Burt, RK
    Kuzel, TM
    Fishman, M
    Brush, M
    Villa, M
    Welles, C
    Rosen, S
    Traynor, AE
    BONE MARROW TRANSPLANTATION, 1999, 23 (04) : 381 - 386
  • [14] Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells
    RK Burt
    TM Kuzel
    M Fishman
    M Brush
    M Villa
    C Welles
    S Rosen
    AE Traynor
    Bone Marrow Transplantation, 1999, 23 : 381 - 386
  • [15] Tumor cell contamiation of bone marrow and peripheral blood stem cells in breast cancer patients.: Prognostic significance.
    Badia, B
    Lluch, A
    Marugán, I
    Solano, C
    Benet, I
    Arbona, C
    Garcia-Conde, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S56 - S56
  • [16] Blood stem cell (BSC) transplantation in metastatic breast cancer using CD34 positive selection with or without negative slection for tumor cells using the Isolex 300® cell separation system.
    Preti, RA
    Pecora, AL
    Jennis, AJ
    Goldberg, S
    Lazarus, H
    Stadtmauer, E
    Winter, J
    Moss, TJ
    BLOOD, 1998, 92 (10) : 492A - 492A
  • [17] CD34+cell selection with the CliniMACS system for haploidentical PBSC (Peripheral Blood Stem Cells) transplantation
    Juncal, C
    Rodrigues, A
    D'Avo, M
    Garçäo, A
    Vilalobos, I
    Duarte, C
    Carmo, JA
    Martins, C
    Lourenço, F
    Galvao, M
    Lacerda, JMF
    Lacerda, JF
    BONE MARROW TRANSPLANTATION, 2001, 27 : S108 - S108
  • [18] Influence of leukapheresis size on subpopulations of CD34(+) cells in peripheral blood stem cell collections.
    Humpe, A
    Schalicke, S
    Riggert, J
    Hiddemann, W
    Wormann, B
    Kohler, M
    TRANSFUSION, 1997, 37 (09) : S317 - S317
  • [19] CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34(+) myeloma cells
    Willems, P
    Croockewit, A
    Raymakers, R
    Holdrinet, R
    VanderBosch, G
    Huys, E
    Mensink, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) : 613 - 622
  • [20] EXPRESSION OF CD34 STEM-CELL ANTIGEN ON TUMOR-CELLS
    KOHLER, G
    BRUGGER, W
    SCHAEFER, HE
    KANZ, L
    BLOOD, 1994, 84 (10) : A497 - A497
12345